News
In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...
Centivax and Emery Pharma Partner to Accelerate Universal Vaccine Clinical Readiness - Yahoo Finance
Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with Emery Pharma, a leading contract research ...
Vaccine development involves a variety of assays to support vaccine research and development, from early preclinical studies to final production, quality control and lot release. ELISA-based assays ...
Table 1. Summary specifications of four viral vaccines. Vaccine Potency Safety Contamination; Smallpox (live vaccinia) 108 pock-forming units per ml ...
Both in vitro and in vivo potency assays are required in order to determine the relationship between antigenicity, immunogenicity and potency and to measure the stability of subunit-based vaccines ...
The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...
NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...
NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...
Potency assay will leverage the product's mechanism of action to define the biological activity. The absence of rigorous mechanistic data for the majority of cell and gene therapy therapeutics ...
NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...
NIIMBL Announces $1.7M from the Global Health Fund for 3 New Vaccine Manufacturing Projects - WGN-TV
NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results